EXHIBIT 99.3

                                                                      [LOGO]
                                                                    ORTHOLOGIC
                                                                    TECHNOLOGY
                                                                   YOU CAN TRUST
                                                                      PROGRAM

                                     [LOGO]
                                   ORTHOLOGIC
        TECHNOLOGY YOU CAN TRUST PROGRAM - CERTIFICATE OF ACKNOWLEDGMENT

IMPORTANT:  PLEASE  SIGN AND RETURN TO  ORTHOLOGIC  WITHIN 30 DAYS OF  RECEIVING
DEVICE. PLEASE MAKE A COPY FOR YOUR OWN RECORDS.

TECHNOLOGY YOU CAN TRUST PROGRAM

If a patient has a nonunion  fracture  that fails to heal and the patient  meets
the  requirements  of the OrthoLogic  Technology You Can Trust Program set forth
below,  the cost paid by the payer(s) of record to OrthoLogic  for the treatment
using the OL1000  will be  refunded  in full by  OrthoLogic  to the  payer(s) of
record.  For purposes of the Technology You Can Trust Program,  payers of record
shall mean the individual or entity who has reimbursed  OrthoLogic  directly for
the OL1000, and may include the patient, provider, supplier, or insurer.

REQUIREMENTS

*    The OL1000 device is prescribed for an FDA-approved indication as listed in
     the OL1000 Physician Manual.

*    The following are excluded conditions:

     -    Synovial pseudarthrosis

     -    Patients using a demand-type pacemaker

     -    Presence  of  internal  fixation  devices  that are  constructed  from
          magnetic materials (most fracture fixation devices used today are made
          of non-magnetic materials)

     -    Pathological fractures (due to bone pathology or malignancy)

     -    Unstable fractures

     -    Fractures of the vertebrae and all flat bones

     -    Fractures  with  gaps  greater  than 50% of the bone  diameter  or one
          centimeter

     -    Fractures  that have been treated with  another  therapy  (invasive or
          noninvasive) after treatment has begun with the OL1000

*    The  Certificate of  Acknowledgment  is completed and signed by the patient
     (to signify the patient's  understanding of the terms and conditions of the
     program)  and  returned  to  OrthoLogic  within  30 days of  initiation  of
     treatment with the OL1000 by the patient.

*    Full payment from the payer(s) is received at OrthoLogic  within 45 days of
     the original invoice date.

*    Claims made under the  Technology You Can Trust Program must be made within
     one year following the date initial treatment begins with the OL1000.

*    Treatment  must continue with the OL1000 for at least 180 days. The patient
     must use the  device  for 30  minutes  per day for at least 89% of the days
     from  the  date  treatment   begins  until  the  date  of  the  prescribing
     physician's  radiographic  assessment  that  there  is  no  progression  to
     healing.  The patient  must use the device in  accordance  with the product
     instructions,  and  compliance  will be  verified by the  treatment  record
     stored in the device.

*    Pre-treatment   and   post-treatment   radiographs   must   demonstrate  no
     progression to healing during the minimum 180-day treatment period.

*    The OL1000 device must not be altered or rendered inoperative in any way.

The requirements of the Technology You Can Trust Program will be fully disclosed
in writing to the patient, and upon request, the payer of record.

CLAIM SUBMISSION

1.   Contact OrthoLogic Customer Support (800.263.6004) for a Claim Form.

2.   Claims made under the  Technology You Can Trust Program must be received by
     OrthoLogic at 1275 W. Washington Street, Tempe, AZ 85281. OrthoLogic is not
     responsible for lost, delayed, misdirected, or improperly addressed claims.

3.   Claims must include:

     a.   The completed Claim Form signed by the treating physician.

     b.   Radiographs  of the fracture site (digital  version  preferred or film
          copy) prior to using the OL1000 device and at the evaluation date.

     c.   The treating  physician's written evaluation of the radiographs at the
          evaluation date.

     d.   The OL1000 device used by the patient.

The patient and treating  physician  will receive  written  notification  of the
claim outcome.

DISCLAIMER

OrthoLogic's  sole  obligation  under this program is to make the  reimbursement
described above where the specified  requirements  are met.  OrthoLogic makes no
other warranty, representation, promise of guarantee, either express or implied,
with  respect to the OL1000  product,  related to  technical  support,  quality,
performance,  merchantability or fitness for a particular purpose,  and all such
representations and warranties are excluded and disclaimed.

OrthoLogic reserves the right to modify or discontinue this program at any time.

Where the payer of record has sought and obtained  reimbursement  for the OL1000
from an  insurer  or other  payer,  the  payer of  record  agrees  to fully  and
accurately  report to such insurer or payer any amounts refunded to the payer of
record by OrthoLogic pursuant to the Technology You Can Trust Program.

See reverse for OL1000 and OL1000 SC brief prescribing information.


I understand the terms and conditions of the OrthoLogic Technology You Can Trust
Program.

PATIENT SIGNATURE ___________________________________________________

DATE ______________________________________________________________
<PAGE>
OL1000 AND OL1000 SC BONE GROWTH STIMULATORS, BRIEF PRESCRIBING INFORMATION

INDICATIONS:

Noninvasive  treatment of an established  nonunion acquired secondary to trauma,
excluding  vertebrae  and  all  flat  bones.  A  nonunion  is  considered  to be
established  when the  fracture  site  shows  no  visibly  progressive  signs of
healing.

CONTRAINDICATIONS:

1.   Use of this  device is  contraindicated  in  individuals  having a synovial
     pseudarthrosis.

2.   Demand-type  pacemaker  operation may be adversely  affected by exposure to
     magnetic   fields.   Physicians   should  not   prescribe  the  OL1000  for
     applications that may place the treatment transducers in close proximity to
     the  pacemaker.   Further  screening  by  the  attending   cardiologist  is
     recommended (such as with an electrocardiogram).

3.   The OL1000  should not be used in the  presence  of  external  or  internal
     fixation devices that are constructed from magnetic materials.  (NOTE: Most
     fracture  fixation  devices  implanted  today  are made  from  non-magnetic
     materials.)

WARNINGS:

1.   The  safety  and  effectiveness  of the use of this  device on  individuals
     lacking skeletal maturity has not been established.

2.   Animal studies  conducted to date do not suggest any long-term  significant
     adverse  effects from use of this  device.  However,  long-term  effects in
     humans are unknown.

3.   The safety of use of this device during  pregnancy or nursing in humans has
     not been established.

PRECAUTIONS:

1.   Weight  bearing is not  advised in the  presence  of extreme  motion at the
     nonunion site.

2.   In the presence of a malaligned nonunion,  careful consideration of the use
     of this device must be undertaken on an individual basis, as treatment with
     this device is not intended to alter or affect the degree of malalignment.

3.   The safety and  effectiveness of the use of this device on individuals with
     nonunion secondary to, or in conjunction with, a pathological condition has
     not been established.

4.   This device  should not be used if there are mental or physical  conditions
     that   preclude   patient   compliance   with  the   physician  and  device
     instructions.

5.   When  conditions  of atrophy are present or when  fractures  have  remained
     unhealed for long periods of time, there may be less successful results.

ADVERSE EFFECTS: No known significant adverse effects have resulted from the use
of this device.

CAUTION:  Federal Law (U.S.A.)  restricts this device to sale by or on the order
of a physician.

FOR FULL PRESCRIBING INFORMATION, CONTACT ORTHOLOGIC.


                                                               68-000-0040 Rev A